Deltyba
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Delamanid
- Made by
- Otsuka Novel Products GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (MDR-TB) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4.2, 4.4 and 5.1). Consideration should be given to official guidance on the appropriate use of antibacterial agents.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Otsuka Novel Products GmbH |
|---|---|
| Active substance | Delamanid |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J04AK06 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2014-04-27 |
| Last updated by the regulator | 2026-03-18 |
| EMA product number | EMEA/H/C/002552 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).